MedTrace Logo

SDOCT-GMPE Software

NCT02235454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2017-07-26

Study results available
· View outcomes & findings →

Summary

The investigators prospectively evaluate the new glaucoma premium edition (GMPE) software for spectral domain optical coherence tomography (SDOCT) and if this software is superior to the conventional one that is currently used for SDOCT.

Conditions

Interventions

DEVICE

SDOCT-GMPE software

Noninvasive imaging of the optic nerve in patients with existing glaucoma

Sponsors & Collaborators

Principal Investigators

  • Sanjay Asrani, MD · Duke Health

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-08-01
Completion
2016-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02235454 on ClinicalTrials.gov